A new collaboration between pharmacy chain Alliance Boots and the Nottingham-based biocluster BioCity took a step forward this week with the appointment of David Browning as director.
MediCity is a subsidiary of BioCity and is based on the Alliance Boots site within the Nottingham Enterprise Zone. It aims to provide start-ups in the health and wellness sector with office and laboratory space.
Browning joins the new venture from healthcare consultancy Paragreen Associates where he served as managing director.
His past experience in healthcare includes a VP role within the healthcare business of Philips and four years as CEO of nanotechnology specialist Oxonica Healthcare.
During this period in charge of Oxonica, Browning worked with Alliance Boots to launch Optisol, an active ingredient in suncare products.
His new role sees him once again working with Alliance Boots, with the company contributing access to innovation and product development knowledge and supply chain expertise to companies involved in MediCity.
Browning’s first task in charge is to oversee the refurbishment and population of MediCity’s base in Nottingham, before leading the call for tenants to take up space.
“I grew up in the East Midlands and I am looking forward to working with talented innovators of new clinical and consumer products,” he said.
“We will draw on a network of business, financial and technical experts, as well as Alliance Boots experience, to help them commercialise their ideas.”